Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgical Oncology
Published in: World Journal of Surgical Oncology 1/2003

Open Access 01-12-2003 | Editorial

Epidermal Growth Factor Receptor: A Novel Target for Anticancer Treatment

Authors: Manoj Pandey, K Chandramohan

Published in: World Journal of Surgical Oncology | Issue 1/2003

Login to get access

Excerpt

The process of cell division, growth, differentiation and death is a highly regulated process. Several class of trans membrane receptors play a pivot role in this process, of these, epidermal growth factor receptor (EGFR) a member of Receptor Tyrosine Kinase (RTK) family are best known. These comprises of four receptors Erb B1/HER 1, Erb B2 / HER 2, Erb B3/ HER 3, and Erb B4 / HER 4. Of these HER 2 is the most favoured target. …
Literature
1.
Janmaat ML, Kruyt FA, Rodriguez JA, Giaccone G: Response to Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer Cells: Limited Antiproliferative Effects and Absence of Apoptosis Associated with Persistent Activity of Extracellular Signal-regulated Kinase or Akt Kinase Pathways. Clin Cancer Res. 2003, 9: 2316-2326.PubMed
2.
Baselga J, Albanell J: Epithelial growth factor receptor interacting agents. Hematol Oncol Clin North Am. 2002, 16: 1041-1063.CrossRefPubMed
3.
Cohen RB: Epidermal growth factor receptor as a therapeutic target in colorectal cancer. Clin Colorectal Cancer. 2003, 2: 246-251.CrossRefPubMed
4.
Delbaldo C, Faivre S, Raymond E: [Epidermal growth factor inhibitors]. Rev Med Interne. 2003, 24: 372-383. 10.1016/S0248-8663(03)00060-2.CrossRefPubMed
5.
Grunwald V, Hidalgo M: Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst. 2003, 95: 851-867. 10.1093/jnci/95.12.851.CrossRefPubMed
6.
Arteaga CL: ErbB-targeted therapeutic approaches in human cancer. Exp Cell Res. 2003, 284: 122-130. 10.1016/S0014-4827(02)00104-0.CrossRefPubMed
7.
8.
Baselga J, Hammond LA: HER-targeted tyrosine-kinase inhibitors. Oncology. 2002, 63 (Suppl 1): 6-16. 10.1159/000066198.CrossRefPubMed
Metadata
Title
Epidermal Growth Factor Receptor: A Novel Target for Anticancer Treatment
Authors
Manoj Pandey
K Chandramohan
Publication date
01-12-2003
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2003
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-1-9

Other articles of this Issue 1/2003

World Journal of Surgical Oncology 1/2003 Go to the issue

Case report

Solitary Plasmacytoma of the Parotid Gland with Crystalline Inclusions: A Case Report

Case report

Tuberculosis and metastatic carcinoma coexistence in axillary lymph node: A case report

Case report

A rare case of breast carcinoma co-existing with axillary mantle cell lymphoma

Case report

Metastatic sweat gland adenocarcinoma: A clinico-pathological dilemma

Case report

Cardiac Tamponade Secondary to Metastasis from Adenocarcinoma of the Parotid Gland

Case report

Laryngeal Involvement of Rhabdomyosarcoma in an Adult